1Nakamura Y, Yanagawa H, Ojima T, et al. Cardiac sequelae of Kawasaki disease among recurrent cases[J]. Arch Dis Child, 1998,78(2): 163 - 165.
2Jason J, Gregg L, Han A, et al. Immunoregulatory changes in Kawasaki disease[J]. Clin Immunol Immunopathol, 1997,84(3):296- 306.
3Mori M, Imagawa T, Yasui K, et al. Predictors of coronary artery lesions after intravenous gamma- globulin treatment in Kawasaki disease[J]. J Pediatr, 2000,137(2):177- 180.
4Falcini F, Trapani S, Turchini S, et al. Immunological findings in Kawasaki disease[J]. Clin Exp Rheumatol, 1997,15(6):685- 689.
5Yoshioa T, Matsutani T, Iwagami S, et al. Polyclonal expansion of TCRBV2-and TCRBV6- bearing T cells in patients with Kawasaki disease[J]. Immunology, 1999,96(3):465- 472
6Kuijpers TW, Wiegman A, Van Lier RA, et al. Kawasaki disease:a maturational defect in immune responsiveness[J]. J Infect Dis,1999,180(6):1869- 1877.
7Yamakawa R, Ishii M, Sugimura T, et al. Coronary endothelial dysfunction after Kawasaki dsease: evaluation by intracoronary injection of acetylcholine[J]. J Am Coll Cardiol, 1998,31(5):1074-1080.
8Dhillon R, Clarkson P, Donald AE, et al. Endothelial dysfunction late after Kawasaki disease[J]. Circulation, 1996,94(9):2103-2106.
9Takabasbi M.The endothelium in Kawasaki disease: the next frontier[J]. J Pediatr, 1998,133(2):177-179.
10Terai M, Yasukawa K, Narumoto S, et al. Vascular endothelial growth factor in acute Kawasaki disease[J]. Am J Cardiol, 1999,83(3):337 - 339.
10[2]Kato H, Sugimura T,A kagi T,et al. Long term consequences of Kawasahi disease.A 10-to-2 1-year follow-up study of 594 patients[J].Circulation, 1996,94(60): 1379-1385.
